A company inspired byREGENERATION

We are Intercept. Our mission is to harness the unique regenerative powers of the liver and build a healthier tomorrow for patients with progressive nonviral liver diseases.


Learn about clinical trials that are currently recruiting:

— Phase III NASH Study

— Phase III PBC Study


Thursday, April 28, 2016

Intercept to Report First Quarter 2016 Financial Results on May 5
See the press release >

You are now being redirected to Intercept’s job application site, hosted by Pereless Systems.